Effect of bright light and melatonin on cognitive and noncognitive function in elderly residents of group care facilities: A randomized controlled trial

JAMA

Volumn 299, Issue 22, 2008, Pages 2642-2655

  Riemersma van Der Lek, Rixt F ^a,d   Swaab, Dick F ^a   Twisk, Jos ^b   Hol, Elly M ^a   Hoogendijk, Witte J G ^b   Van Someren, Eus J W ^a,b,c  

^a NETHERLANDS INSTITUTE FOR NEUROSCIENCE   (Netherlands)

^b VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^c VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^d UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT; ANXIOLYTIC AGENT; HYPNOTIC AGENT; MELATONIN; NEUROLEPTIC AGENT; PLACEBO;

AGED; AGGRESSION; ARTICLE; BEHAVIOR DISORDER; CIRCADIAN RHYTHM; CLINICAL TRIAL; COGNITION; COGNITIVE DEFECT; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DAILY LIFE ACTIVITY; DEMENTIA; DEPRESSION; DISEASE COURSE; DOUBLE BLIND PROCEDURE; FEMALE; FOLLOW UP; FUNCTIONAL DISEASE; HUMAN; LIGHT EXPOSURE; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; MENTAL DETERIORATION; MINI MENTAL STATE EXAMINATION; MOOD DISORDER; MULTICENTER STUDY; NIGHT SLEEP; PHOTOTHERAPY; PRESCRIPTION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RATING SCALE; RESTLESSNESS; SLEEP DISORDER; SLEEP INDUCTION; UNSPECIFIED SIDE EFFECT; VISUAL IMPAIRMENT; AFFECT; DRUG EFFECT; HOME FOR THE AGED; ILLUMINATION; LIGHT; MULTIMODALITY CANCER THERAPY; NURSING HOME; SLEEP;

ACTIVITIES OF DAILY LIVING; AFFECT; AGED, 80 AND OVER; CIRCADIAN RHYTHM; COGNITION; COMBINED MODALITY THERAPY; DEMENTIA; DEPRESSION; DOUBLE-BLIND METHOD; FEMALE; HOMES FOR THE AGED; HUMANS; LIGHT; LIGHTING; MALE; MELATONIN; NURSING HOMES; PHOTOTHERAPY; SLEEP; SLEEP DISORDERS;

EID: 44949175084     PISSN: 00987484     EISSN: 15383598     Source Type: Journal    
DOI: 10.1001/jama.299.22.2642     Document Type: Article

References (62)

1. Lee HB, Lyketsos CG. Depression in Alzheimer's disease: heterogeneity and related issues. Biol Psychiatry. 2003;54(3):353-362.
2. Purandare N, Burns A, Craig S, Faragher B, Scott K. Depressive symptoms in patients with Alzheimer's disease. Int J Geriatr Psychiatry. 2001;16(10):960-964.
3. González-Salvador T, Lyketsos CG, Baker A, et al. Quality of life in dementia patients in long-term care. Int J Geriatr Psychiatry. 2000;15(2):181-189.
4. Donaldson C, Tarrier N, Burns A. Determinants of carer stress in Alzheimer's disease. Int J Geriatr Psychiatry. 1998;13(4):248-256.
5. Dorenlot P, Harboun M, Bige V, Henrard JC, Ankri J. Major depression as a risk factor for early institutionalization of dementia patients living in the community. Int J Geriatr Psychiatry. 2005;20(5):471-478.
6. Devanand DP, Jacobs DM, Tang MX, et al. The course of psychopathologic features in mild to moderate Alzheimer disease. Arch Gen Psychiatry. 1997;54(3):257-263.
7. Banerjee S, Murray J, Foley B, Atkins L, Schneider J, Mann A. Predictors of institutionalisation in people with dementia. J Neurol Neurosurg Psychiatry. 2003;74(9):1315-1316.
8. Courtney C, Farrell D, Gray R, et al. Long-term donepezil treatment in 565 patients with Alzheimer's disease (AD2000): randomised double-blind trial. Lancet. 2004;363(9427):2105-2115.
9. Sink KM, Holden KF, Yaffe K. Pharmacological treatment of neuropsychiatric symptoms of dementia: a review of the evidence. JAMA. 2005;293(5):596-608.
10. Van Someren EJW. Circadian and sleep disturbances in the elderly. Exp Gerontol. 2000;35(9-10):1229-1237.
11. Salzman C, Wong E, Wright BC. Drug and ECT treatment of depression in the elderly, 1996-2001: a literature review. Biol Psychiatry. 2002;52(3):265-284.
12. Fekete M, van Ree JM, Niesink RJ, de Wied D. Disrupting circadian rhythms in rats induces retrograde amnesia. Physiol Behav. 1985;34(6):883-887.
13. Cho K. Chronic 'jet lag' produces temporal lobe atrophy and spatial cognitive deficits. Nat Neurosci. 2001;4(6):567-568.
14. Walker MP, Stickgold R. Sleep-dependent learning and memory consolidation. Neuron. 2004;44(1):121-133.
15. Swaab DF, Fliers E, Partiman TS. The suprachiasmatic nucleus of the human brain in relation to sex, age and senile dementia. Brain Res. 1985;342(1):37-44.
16. Zhou JN, Riemersma RF, Unmehopa UA, et al. Alterations in arginine vasopressin neurons in the suprachiasmatic nucleus in depression. Arch Gen Psychiatry. 2001;58(7):655-662.
17. Liu RY, Zhou JN, Hoogendijk WJG, et al. Decreased vasopressin gene expression in the biological clock of Alzheimer's disease patients with and without depression. J Neuropathol Exp Neurol. 2000;59(4):314-322.
18. Moe KE, Vitiello MV, Larsen LH, Prinz PN. Sleep/wake patterns in Alzheimer's disease: relationships with cognition and function. J Sleep Res. 1995;4(1):15-20.
19. Moore RY. Entrainment pathways and the functional organization of the circadian system. Prog Brain Res. 1996;111:103-119.
20. Van Someren EJW, Riemersma RF, Swaab DF. Functional plasticity of the circadian timing system in old age: light exposure. Prog Brain Res. 2002;138:205-231.
21. Riemersma RF, Mattheij CAM, Swaab DF, Van Someren EJW. Melatonin rhythms, melatonin supplementation and sleep in old age. In: Straub RH, Mocchegiani E, eds. The Neuroendocrine Immune Network in Ageing. Vol 4. Amsterdam, the Netherlands: Elsevier; 2004:195-211.
22. Mishima K, Okawa M, Hishikawa Y, Hozumi S, Hori H, Takahashi K. Morning bright light therapy for sleep and behavior disorders in elderly patients with dementia. Acta Psychiatr Scand. 1994;89(1):1-7.
23. Tunis SR, Stryer DB, Clancy CM. Practical clinical trials: increasing the value of clinical research for decision making in clinical and health policy. JAMA. 2003;290(12):1624-1632.
24. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 4th ed. Washington, DC: American Psychiatric Association; 1994.
25. McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology. 1984;34(7):939-944.
26. Sloane PD, Mathew LJ. The Therapeutic Environment Screening Scale. Am J Alz Care Related Disord Res. 1990;5(1):22-26.
27. Slaughter S, Calkins M, Eliasziw M, Reimer M. Measuring physical and social environments in nursing homes for people with middle- to late-stage dementia. J Am Geriatr Soc. 2006;54(9):1436-1441.
28. Zhdanova IV, Lynch HJ, Wurtman RJ. Melatonin - a sleep-promoting hormone. Sleep. 1997;20(10):899-907.
29. Singer C, Tractenberg RE, Kaye J, et al. A multicenter, placebo-controlled trial of melatonin for sleep disturbance in Alzheimer's disease. Sleep. 2003;26(7):893-901.
30. Tozawa T, Mishima K, Satoh K, et al. Melatonin replacement therapy for rest-activity rhythm disorders in patients with senile dementia of the Alzheimer type. Neurobiol Aging. 1998;19(4S):S182.
31. Middleton B, Stone BM, Arendt J. Human circadian phase in 12:12 h, 200: <-8 lux and 1000: <-8 lux light-dark cycles, without scheduled sleep or activity. Neurosci Lett. 2002;329(1):41-44.
32. Van Someren EJW, Kessler A, Mirmiran M, Swaab DF. Indirect bright light improves circadian rest-activity rhythm disturbances in demented patients. Biol Psychiatry. 1997;41(9):955-963.
33. Folstein MF, Folstein SE, McHugh PR. "Minimental state": a practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res. 1975;12(3):189-198.
34. Alexopoulos GS, Abrams RC, Young RC, Shamoian CA. Cornell scale for depression in dementia. Biol Psychiatry. 1988;23(3):271-284.
35. Harwood DG, Ownby RL, Barker WW, Duara R. The factor structure of the Cornell Scale for Depression in Dementia among probable Alzheimer's disease patients. Am J Geriatr Psychiatry. 1998;6(3):212-220.
36. Lawton MP. The Philadelphia Geriatric Center Morale Scale: a revision. J Gerontol. 1975;30(1):85-89.
37. Ryden MB, Knopman D. Assess not assume-measuring the morale of cognitively impaired elderly. J Gerontol Nurs. 1989;15(11):27-32.
38. Lawton MP, Van Haitsma K, Klapper J. Observed affect in nursing home residents with Alzheimer's disease. J Gerontol B Psychol Sci Soc Sci. 1996;51(1):P3-P14.
39. Helmes E, Csapo KG, Short JA. Standardization and validation of the Multidimensional Observation Scale for Elderly Subjects (MOSES). J Gerontol. 1987;42(4):395-405.
40. Kaufer DI, Cummings JL, Ketchel P, et al. Validation of the NPI-Q, a brief clinical form of the Neuropsychiatric Inventory. J Neuropsychiatry Clin Neurosci. 2000;12(2):233-239.
41. de Jonghe JF, Kat MG, Kalisvaart CJ, Boelaarts L. Neuropsychiatric Inventory Questionnaire (NPI-Q): a validity study of the Dutch form [in Dutch]. Tijdschr Gerontol Geriatr. 2003;34(2):74-77.
42. Cohen-Mansfield J, Marx MS, Rosenthal AS. A description of agitation in a nursing home. J Gerontol. 1989;44(3):M77-M84.
43. de Jonghe JF, Kat MG. Factor structure and validity of the Dutch version of the Cohen-Mansfield Agitation Inventory (CMAI-D). J Am Geriatr Soc. 1996;44(7):888-889.
44. Holmes D, Teresi J, Weiner A, Monaco C, Ronch J, Vickers R. Impacts associated with special care units in long-term care facilities. Gerontologist. 1990;30(2):178-183.
45. Katz S, Ford AB, Moskowitz RW, Jackson BA, Jaffe MW. The index of ADL: a standardized measure of biological and psychosocial function. JAMA. 1963;185:914-919.
46. Ancoli-Israel S, Clopton P, Klauber MR, Fell R, Mason W. Use of wrist activity for monitoring sleep/wake in demented nursing-home patients. Sleep. 1997;20(1):24-27.
47. Kushida CA, Chang A, Gadkary C, Guilleminault C, Carrillo O, Dement WC. Comparison of actigraphic, polysomnographic, and subjective assessment of sleep parameters in sleep-disordered patients. Sleep Med. 2001;2(5):389-396.
48. Van Someren EJW. Improving actigraphic sleep estimates: how many nights? J Sleep Res. 2007;16(3):269-275.
49. Van Someren EJW, Swaab DF, Colenda CC, Cohen W, McCall WV, Rosenquist PB. Bright light therapy: improved sensitivity to its effects on rest-activity rhythms in Alzheimer patients by application of non-parametric methods. Chronobiol Int. 1999;16(4):505-518.
50. Gimeno V, Sagales T, Miguel L, Ballarin M. The statistical distribution of wrist movements during sleep. Neuropsychobiology. 1998;38(2):108-112.
51. Twisk JWR. Applied Longitudinal Data Analysis for Epidemiology. Cambridge, England: Cambridge University Press; 2003:280.
52. Gibbons RD, Hedeker D, Elkin I, et al. Some conceptual and statistical issues in analysis of longitudinal psychiatric data: application to the NIMH treatment of Depression Collaborative Research Program dataset. Arch Gen Psychiatry. 1993;50(9):739-750.
53. Petkova E, Teresi J. Some statistical issues in the analyses of data from longitudinal studies of elderly chronic care populations. Psychosom Med. 2002;64(3):531-547.
54. Siddiqui O, Ali MW. A comparison of the random-effects pattern mixture model with last-observation-carried-forward (LOCF) analysis in longitudinal clinical trials with dropouts. J Biopharm Stat. 1998;8(4):545-563.
55. Zhdanova IV, Wurtman RJ, Regan MM, Taylor JA, Shi JP, Leclair OU. Melatonin treatment for age-related insomnia. J Clin Endocrinol Metab. 2001;86(10):4727-4730.
56. Carman JS, Post RM, Buswell R, Goodwin FK. Negative effects of melatonin on depression. Am J Psychiatry. 1976;133(10):1181-1186.
57. Edinger JD, Bonnet MH, Bootzin RR, et al. Derivation of research diagnostic criteria for insomnia: report of an American Academy of Sleep Medicine Work Group. Sleep. 2004;27(8):1567-1596.
58. Serfaty M, Kennell-Webb S, Warner J, Blizard R, Raven P. Double blind randomised placebo controlled trial of low dose melatonin for sleep disorders in dementia. Int J Geriatr Psychiatry. 2002;17(12):1120-1127.
59. Caspi A, Sugden K, Moffitt TE, et al. Influence of life stress on depression: moderation by a polymorphism in the 5-HTT gene. Science. 2003;301(5631):386-389.
60. Van Someren EJW, Riemersma-Van Der Lek RF. Live to the rhythm, slave to the rhythm. Sleep Med Rev. 2007;11(6):465-484.
61. Burback D, Molnar FJ, St John P, Man-Son-Hing M. Key methodological features of randomized controlled trials of Alzheimer's disease therapy: Minimal clinically important difference, sample size and trial duration. Dement Geriatr Cogn Disord. 1999;10(6):534-540.
62. Kavirajan H, Schneider LS. Efficacy and adverse effects of cholinesterase inhibitors and memantine in vascular dementia: a meta-analysis of randomised controlled trials. Lancet Neurol. 2007;6(9):782-792.